Richard G Moore Selected Research

Richard G Moore Research Topics

Disease

36	Neoplasms (Cancer) 05/2022 - 04/2002
33	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2006
15	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 08/2008
8	Ovarian Epithelial Carcinoma 01/2021 - 09/2007
4	Endometrioid Carcinoma 05/2022 - 08/2008
4	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2002
4	Carcinogenesis 01/2020 - 01/2014
3	Carcinoma (Carcinomatosis) 05/2022 - 02/2008
3	Neuroblastoma 01/2022 - 04/2011
3	Hypercalcemia (Milk Alkali Syndrome) 11/2013 - 11/2011
2	Disease Progression 12/2019 - 07/2014
2	Vulvar Neoplasms (Vulvar Cancer) 11/2003 - 06/2003
1	Hyperandrogenism 05/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Anemia 01/2022
1	Fallopian Tube Neoplasms 01/2022
1	Fatigue 01/2022
1	Adenocarcinoma 01/2021
1	Ascites 01/2021
1	Leukemia 11/2015
1	Hypoxia (Hypoxemia) 10/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2011
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2007
7	PlatinumIBA 01/2022 - 11/2013
6	Pharmaceutical PreparationsIBA 08/2012 - 02/2007
4	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 01/2014
3	niraparibIBA 01/2022 - 12/2019
3	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 11/2015 - 04/2012
3	AntioxidantsIBA 05/2015 - 07/2011
3	Vitamin D FDA LinkGeneric 11/2013 - 11/2011
3	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 11/2013 - 11/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 04/2002
3	Tumor Biomarkers (Tumor Markers)IBA 10/2011 - 02/2008
2	Hormones (Hormone)IBA 05/2022 - 06/2014
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019 - 11/2015
2	CopperIBA 10/2015 - 04/2012
2	Tamoxifen FDA LinkGeneric 06/2014 - 05/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2012 - 01/2012
1	AntigensIBA 05/2022
1	Aromatase (CYP19)IBA 05/2022
1	EnzymesIBA 05/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2022
1	SteroidsIBA 05/2022
1	Testosterone (Sustanon)FDA Link 05/2022
1	Transferrin (beta 2 Transferrin)IBA 03/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022
1	7-dehydrocholesterolIBA 01/2022
1	olaparibIBA 01/2022
1	cediranib (AZD2171)IBA 01/2022
1	ArginaseIBA 01/2021
1	CytokinesIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	TrypsinIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	CytokininsIBA 01/2020
1	PAR-2 ReceptorIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	N-(2-chloro-4-pyridyl)-N'-phenylureaIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2019
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 11/2015
1	Caspase 3 (Caspase-3)IBA 11/2015
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	PS121912IBA 11/2015
1	JNK Mitogen-Activated Protein KinasesIBA 11/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	Oxygen (Dioxygen)IBA 10/2015
1	ORALIT (ORS)IBA 09/2015
1	FlavonoidsIBA 05/2015
1	QuercetinIBA 05/2015
1	Carboplatin (JM8)FDA LinkGeneric 07/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2014
1	taxaneIBA 07/2014
1	Estrogen ReceptorsIBA 06/2014
1	Ivermectin (Mectizan)FDA Link 06/2014
1	Fulvestrant (Faslodex)FDA Link 06/2014
1	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2014
1	Karyopherins (Importin)IBA 06/2014
1	WAP Four-Disulfide Core Domain Protein 2IBA 01/2014
1	OligonucleotidesIBA 01/2014

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2007
11	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
2	Hysterectomy 11/2018 - 05/2017
2	Lymph Node Excision (Lymph Node Dissection) 05/2017 - 10/2011
2	Conservative Treatment 11/2015 - 04/2008
1	Radiotherapy 11/2018
1	Tubal Sterilization (Tubal Ligation) 09/2015